<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0795">
 <label>159</label>
 <element-citation publication-type="journal" id="rf0770">
  <person-group person-group-type="author">
   <name>
    <surname>Uesato</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kitagawa</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kaijima</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Tokuda</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Okuda</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mou</surname>
    <given-names>X.Y.</given-names>
   </name>
  </person-group>
  <article-title>Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation</article-title>
  <source>Cancer Lett.</source>
  <volume>166</volume>
  <issue>2</issue>
  <year>2001</year>
  <fpage>143</fpage>
  <lpage>146</lpage>
  <comment>May 26</comment>
  <pub-id pub-id-type="pmid">11311486</pub-id>
 </element-citation>
</ref>
